220 related articles for article (PubMed ID: 31223289)
1. CSN6 Promotes the Migration and Invasion of Cervical Cancer Cells by Inhibiting Autophagic Degradation of Cathepsin L.
Mao Z; Sang MM; Chen C; Zhu WT; Gong YS; Pei DS
Int J Biol Sci; 2019; 15(6):1310-1324. PubMed ID: 31223289
[TBL] [Abstract][Full Text] [Related]
2. CSN6 controls the proliferation and metastasis of glioblastoma by CHIP-mediated degradation of EGFR.
Hou J; Deng Q; Zhou J; Zou J; Zhang Y; Tan P; Zhang W; Cui H
Oncogene; 2017 Feb; 36(8):1134-1144. PubMed ID: 27546621
[TBL] [Abstract][Full Text] [Related]
3. CSN6 promotes the cell migration of breast cancer cells by positively regulating Snail1 stability.
Mou J; Wei L; Liang J; Du W; Pei D
Int J Med Sci; 2020; 17(17):2809-2818. PubMed ID: 33162808
[No Abstract] [Full Text] [Related]
4. Downregulation of CSN6 attenuates papillary thyroid carcinoma progression by reducing Wnt/β-catenin signaling and sensitizes cancer cells to FH535 therapy.
Wen D; Liao T; Ma B; Qu N; Shi RL; Lu ZW; Wang YL; Wei WJ; Ji QH
Cancer Med; 2018 Feb; 7(2):285-296. PubMed ID: 29341469
[TBL] [Abstract][Full Text] [Related]
5. CSN6 promotes melanoma proliferation and metastasis by controlling the UBR5-mediated ubiquitination and degradation of CDK9.
Zhang Y; Hou J; Shi S; Du J; Liu Y; Huang P; Li Q; Liu L; Hu H; Ji Y; Guo L; Shi Y; Liu Y; Cui H
Cell Death Dis; 2021 Jan; 12(1):118. PubMed ID: 33483464
[TBL] [Abstract][Full Text] [Related]
6. The Emerging Role of CSN6 in Biological Behavior and Cancer Progress.
Mao Z; Chen C; Pei DS
Anticancer Agents Med Chem; 2019; 19(10):1198-1204. PubMed ID: 30961513
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of CSN6 promotes the epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.
Xu M; Zhen L; Lin L; Wu K; Wang Y; Cai X
Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):340-348. PubMed ID: 31422034
[TBL] [Abstract][Full Text] [Related]
8. CSN6 inhibition suppresses pancreatic adenocarcinoma metastasis via destabilizing the c-Fos protein.
Ma F; Wang H; Liu K; Wang Z; Chen S
Exp Cell Res; 2020 Jun; 391(1):112004. PubMed ID: 32289284
[TBL] [Abstract][Full Text] [Related]
9. CUL4A regulates endometrial cancer cell proliferation, invasion and migration by interacting with CSN6.
Wang X; Chen T
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179082
[TBL] [Abstract][Full Text] [Related]
10. Regulating the stability and localization of CDK inhibitor p27(Kip1) via CSN6-COP1 axis.
Choi HH; Guma S; Fang L; Phan L; Ivan C; Baggerly K; Sood A; Lee MH
Cell Cycle; 2015; 14(14):2265-73. PubMed ID: 25945542
[TBL] [Abstract][Full Text] [Related]
11. COP9 signalosome subunit 6 (CSN6) regulates E6AP/UBE3A in cervical cancer.
Gao S; Fang L; Phan LM; Qdaisat A; Yeung SC; Lee MH
Oncotarget; 2015 Sep; 6(29):28026-41. PubMed ID: 26318036
[TBL] [Abstract][Full Text] [Related]
12. CSN6 aggravates Ang II-induced cardiomyocyte hypertrophy via inhibiting SIRT2.
Mei ZL; Wang HB; Hu YH; Xiong L
Exp Cell Res; 2020 Nov; 396(1):112245. PubMed ID: 32882218
[TBL] [Abstract][Full Text] [Related]
13. CSN6 positively regulates c-Jun in a MEKK1-dependent manner.
Shin J; Phan L; Chen J; Lu Z; Lee MH
Cell Cycle; 2015; 14(19):3079-87. PubMed ID: 26237449
[TBL] [Abstract][Full Text] [Related]
14. CSN6 expression is associated with pancreatic cancer progression and predicts poor prognosis.
Shi J; Guan X; Zhan F; Liu C; Li Z; Yao Y; Wang B; Lou C; Zhang Y
Cancer Biol Ther; 2019; 20(9):1290-1299. PubMed ID: 31311398
[TBL] [Abstract][Full Text] [Related]
15. EGFR-ERK pathway regulates CSN6 to contribute to PD-L1 expression in glioblastoma.
Su L; Guo W; Lou L; Nie S; Zhang Q; Liu Y; Chang Y; Zhang X; Li Y; Shen H
Mol Carcinog; 2020 May; 59(5):520-532. PubMed ID: 32134157
[TBL] [Abstract][Full Text] [Related]
16. CSN6 drives carcinogenesis by positively regulating Myc stability.
Chen J; Shin JH; Zhao R; Phan L; Wang H; Xue Y; Post SM; Ho Choi H; Chen JS; Wang E; Zhou Z; Tseng C; Gully C; Velazquez-Torres G; Fuentes-Mattei E; Yeung G; Qiao Y; Chou PC; Su CH; Hsieh YC; Hsu SL; Ohshiro K; Shaikenov T; Wang H; Yeung SC; Lee MH
Nat Commun; 2014 Nov; 5():5384. PubMed ID: 25395170
[TBL] [Abstract][Full Text] [Related]
17. Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers.
Zhao R; Yeung SC; Chen J; Iwakuma T; Su CH; Chen B; Qu C; Zhang F; Chen YT; Lin YL; Lee DF; Jin F; Zhu R; Shaikenov T; Sarbassov D; Sahin A; Wang H; Wang H; Lai CC; Tsai FJ; Lozano G; Lee MH
J Clin Invest; 2011 Mar; 121(3):851-65. PubMed ID: 21317535
[TBL] [Abstract][Full Text] [Related]
18. CSN6 promotes malignant progression of oral squamous cell carcinoma by down-regulating TIMP-2.
Gao WY; Yang G; Wang J; He JM; Wang P
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5419-5428. PubMed ID: 32495877
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of cysteine cathepsin L is a marker of invasion and metastasis in ovarian cancer.
Zhang W; Wang S; Wang Q; Yang Z; Pan Z; Li L
Oncol Rep; 2014 Mar; 31(3):1334-42. PubMed ID: 24402045
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin L promotes ionizing radiation-induced U251 glioma cell migration and invasion through regulating the GSK-3β/CUX1 pathway.
Fei Y; Xiong Y; Shen X; Zhao Y; Zhu Y; Wang L; Liang Z
Cell Signal; 2018 Apr; 44():62-71. PubMed ID: 29331585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
